HOPES that multiple sclerosis, a devastating neurological disease with no cure, could be treated with antibiotics are fading. Last summer, researchers announced that they had found a bacterium, Chlamydia pneumoniae, in the spinal fluid of most MS patients, raising hopes of a treatment.
But now Margaret Hammerschlag, who runs the Chlamydia Research Laboratory at the State University of New York ÎçÒ¹¸£Àû1000¼¯ºÏ Science Center in Brooklyn, has failed to find any trace of the bacterium in the spinal fluid of 48 MS patients and 51 healthy controls (Neurology, vol 54, p 265). Hammerschlag says that the lack of standardised laboratory tests…
